Interferon beta-1a treatment in HTLV-1-associated myelopathy/tropical spastic paraparesis: a case report (Q34230066)

31 July 2017

0 references

Interferon beta-1a treatment in HTLV-1-associated myelopathy/tropical spastic paraparesis: a case report (English)

1 reference

Human T-lymphotropic virus 1

31 July 2017

0 references

1 reference

1 reference

Graça Maria de Castro Viana

1

1 reference

31 July 2017

Marcos Antonio Custódio Neto da Silva

2

1 reference

31 July 2017

Victor Lima Souza

3

1 reference

31 July 2017

Natália Barbosa da Silva Lopes

4

1 reference

31 July 2017

Diego Luz Felipe da Silva

5

1 reference

31 July 2017

Maria do Desterro Soares Brandão Nascimento

6

1 reference

31 July 2017

1 September 2014

1 reference

Revista do Instituto de Medicina Tropical de São Paulo

31 July 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

31 July 2017

56

1 reference

31 July 2017

5

1 reference

31 July 2017

443-445

1 reference

Interferon Beta-1a Improves Urinary Symptoms, Reduces Proviral Load, and Modifies the Immune Response in a Patient with HAM/TSP.

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172118

Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172118

Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172118

Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172118

Human T-cell lymphotropic virus type 1(HTLV-1)-associated myelopathy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172118

Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172118

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172118

Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172118

Frequency of mental disturbances in HTLV-1 patients in the state of Bahia, Brazil

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1590%2FS0036-46652014000500013

Clinical and immunological features of patients with atopy and concomitant HTLV-1 infection.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1590%2FS0036-46652014000500013

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25229227

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1590/S0036-46652014000500013

1 reference

31 July 2017

1 reference

31 July 2017

1 reference